TMG recently reported its 1HFY2025 ended December 2024 results, which saw a net loss of $12.9 million mainly due to the poor performance in its Malaysian operations and increased interest expenses related to the acquisition of FV Hospital in Vietnam.
Maybank Securities has downgraded its call on Thomson Medical Group (SGX:A50
) (TMG) to “hold” from “buy” with a slightly lower target price of 5 cents from 6 cents previously.
In its Feb 13 report, analyst Eric Ong says: “While we are still positive on TMG’s long-term growth strategy, we think the group needs a bit more time to fully reap the benefits of maximising its assets and enhancing margins in its three key markets.”
